| 337 | Humans |
| 217 | Female |
| 167 | Male |
| 153 | Middle Aged |
| 140 | Adult |
| 107 | Aged |
| 94 | Animals |
| 87 | Lymphedema |
| 75 | Lymphedema (etiology) |
| 55 | Lymphedema (diagnosis) |
| 53 | Human |
| 44 | Lymphedema (pathology) |
| 39 | Lymphedema (therapy) |
| 38 | Adolescent |
| 37 | Treatment Outcome |
| 36 | Aged, 80 and over |
| 34 | Diagnosis, Differential |
| 29 | Follow-Up Studies |
| 28 | Young Adult |
| 28 | Lymphedema (surgery) |
| 28 | Case study |
| 27 | Treatment |
| 26 | Lymphedema (diagnostic imaging) |
| 26 | Lymphedema (complications) |
| 24 | Breast Neoplasms (surgery) |
| 22 | Time Factors |
| 22 | Syndrome |
| 21 | Retrospective Studies |
| 21 | Lymphedema (physiopathology) |
| 21 | Elephantiasis, Filarial (drug therapy) |
| 20 | Complication |
| 20 | Combined Modality Therapy |
| 20 | Child |
| 18 | Elephantiasis, Filarial (parasitology) |
| 17 | Lymphedema (genetics) |
| 16 | Quality of Life |
| 16 | Chronic Disease |
| 15 | Leg |
| 15 | Drainage |
| 14 | Lymphoscintigraphy |
| 14 | Lymphedema (drug therapy) |
| 14 | Lymphatic Vessels (pathology) |
| 14 | Breast Neoplasms (radiotherapy) |
| 13 | Lymphatic Metastasis |
| 13 | Filaricides (therapeutic use) |
| 12 | Surveys and Questionnaires |
| 12 | Skin Neoplasms (pathology) |
| 12 | Recurrence |
| 12 | Prospective Studies |
| 12 | Lymphography (methods) |
| 12 | Lymphedema (prevention & control) |
| 12 | Elephantiasis, Filarial (epidemiology) |
| 11 | Prognosis |
| 11 | Phenotype |
| 11 | Mice |
| 11 | Malignant tumor |
| 11 | Lymphography |
| 11 | Lower limb |
| 11 | Elephantiasis, Filarial (immunology) |
| 11 | Disease Models, Animal |
| 11 | Diagnosis |
| 11 | Child, Preschool |
| 11 | Biopsy |
| 10 | Sensitivity and Specificity |
| 10 | Physical Therapy Modalities |
| 10 | Mastectomy |
| 10 | Magnetic Resonance Imaging (methods) |
| 10 | Lymphedema (psychology) |
| 10 | Lymph Node Excision |
| 10 | Lymph Node Excision (adverse effects) |
| 10 | Cardiovascular disease |
| 10 | Breast Neoplasms (pathology) |
| 10 | Arm |
| 9 | Ultrasonography |
| 9 | Transplantation, Autologous |
| 9 | Survival Analysis |
| 9 | Risk Factors |
| 9 | Microsurgery |
| 9 | Magnetic Resonance Imaging |
| 9 | Lymphedema (metabolism) |
| 9 | Lymphatic system |
| 9 | Lymphatic Vessels (surgery) |
| 9 | Lymphangiogenesis |
| 9 | Infant |
| 9 | Germany |
| 9 | Association |
| 8 | Tomography, X-Ray Computed |
| 8 | Surgery |
| 8 | Risk Assessment |
| 8 | Reproducibility of Results |
| 8 | Rats |
| 8 | Neoplasm Staging |
| 8 | Lymphedema (rehabilitation) |
| 8 | Lymphatic Vessels (transplantation) |
| 8 | Lymph (physiology) |
| 8 | Leg (pathology) |
| 8 | Leg (diagnostic imaging) |
| 8 | Edema (etiology) |
| 8 | Drug Administration Schedule |
| 8 | Drainage (methods) |
| 8 | Dermatology |
| 8 | Cross-Sectional Studies |
| 8 | Contrast Media |
| 8 | Breast Neoplasms (therapy) |
| 8 | Breast Neoplasms (complications) |
| 8 | Axilla |
| 8 | Anti-Bacterial Agents (therapeutic use) |
| 7 | Wuchereria bancrofti (isolation & purification) |
| 7 | Pain Measurement |
| 7 | Microsurgery (methods) |
| 7 | Mammary gland |
| 7 | Lymphatic |
| 7 | Lymphatic Vessels (diagnostic imaging) |
| 7 | Lymphatic System (physiology) |
| 7 | Lymphatic System (pathology) |
| 7 | Lymph Nodes (transplantation) |
| 7 | Lymph Nodes (pathology) |
| 7 | Leg (surgery) |
| 7 | Infant, Newborn |
| 7 | Gadolinium DTPA |
| 7 | Endothelial Cells (cytology) |
| 7 | Doxycycline (therapeutic use) |
| 7 | Contrast Media (administration & dosage) |
| 7 | Chronic |
| 7 | Chemotherapy, Adjuvant |
| 6 | Skin |
| 6 | Skin Neoplasms (complications) |
| 6 | Severity of Illness Index |
| 6 | Regeneration |
| 6 | Radiotherapy |
| 6 | Radiotherapy, Adjuvant (adverse effects) |
| 6 | Postoperative Complications (surgery) |
| 6 | Physiotherapy |
| 6 | Onchocerciasis (drug therapy) |
| 6 | Nuclear magnetic resonance imaging |
| 6 | Mutation |
| 6 | Lymphangiogenesis (physiology) |
| 6 | Lymph Node Excision (methods) |
| 6 | Karyotyping |
| 6 | In Situ Hybridization, Fluorescence |
| 6 | Genital Diseases, Male (surgery) |
| 6 | Feasibility Studies |
| 6 | Elephantiasis, Filarial (transmission) |
| 6 | Elephantiasis, Filarial (prevention & control) |
| 6 | Anastomosis, Surgical |
| 6 | Age Factors |
| 6 | Adipose Tissue (pathology) |
| 5 | Upper limb |
| 5 | Transplantation |
| 5 | Symptomatology |
| 5 | Swine |
| 5 | Sodium Selenite (therapeutic use) |
| 5 | Skin Neoplasms (surgery) |
| 5 | Randomized Controlled Trials as Topic |
| 5 | Radiotherapy, Adjuvant |
| 5 | Radiotherapy (adverse effects) |
| 5 | Radiation Injuries (etiology) |
| 5 | Prevalence |
| 5 | Preoperative Care |
| 5 | Predictive Value of Tests |
| 5 | Practice Guidelines as Topic |
| 5 | Postoperative |
| 5 | Postoperative Complications (prevention & control) |
| 5 | Postoperative Complications (etiology) |
| 5 | Postoperative Care |
| 5 | Polymerase Chain Reaction (methods) |
| 5 | Pedigree |
| 5 | Neoplasms (surgery) |
| 5 | Muridae |
| 5 | Molecular Sequence Data |
| 5 | Mastectomy, Segmental |
| 5 | Lymphedema (epidemiology) |
| 5 | Lymphedema (congenital) |
| 5 | Lymphatic vessel disease |
| 5 | Lymphatic Vessels (physiopathology) |
| 5 | Lymphatic Vessels (physiology) |
| 5 | Lymphatic Vessels (metabolism) |
| 5 | Lymphatic Vessels (embryology) |
| 5 | Lymphatic System (surgery) |
| 5 | Ivermectin (therapeutic use) |
| 5 | Incidence |
| 5 | Immunoglobulin G (blood) |
| 5 | Imaging, Three-Dimensional |
| 5 | Hemangiosarcoma (pathology) |
| 5 | Gadolinium |
| 5 | Filaricides (pharmacology) |
| 5 | Filaricides (administration & dosage) |
| 5 | Exploration |
| 5 | Erysipelas |
| 5 | Endothelial Cells (metabolism) |
| 5 | Elephantiasis, Filarial (diagnostic imaging) |
| 5 | Elephantiasis, Filarial (diagnosis) |
| 5 | Elephantiasis (surgery) |
| 5 | Edema (diagnosis) |
| 5 | Dogs |
| 5 | Cohort Studies |
| 5 | Cisplatin (administration & dosage) |
| 5 | Bandages |
| 5 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 5 | Antibodies, Helminth (blood) |
| 5 | Algorithms |
| 5 | Abnormalities, Multiple (pathology) |
| 5 | Abnormalities, Multiple (genetics) |
| 4 | Wuchereria bancrofti (immunology) |
| 4 | Wuchereria bancrofti (drug effects) |
| 4 | Wound Healing (physiology) |
| 4 | Venous Thrombosis (diagnosis) |
| 4 | Technique |
| 4 | Swine, Miniature |
| 4 | Survival Rate |
| 4 | Surgical Flaps |
| 4 | Soft Tissue Neoplasms (surgery) |
| 4 | Soft Tissue Neoplasms (pathology) |
| 4 | Skin Neoplasms (diagnosis) |
| 4 | Skin (pathology) |
| 4 | Scrotum |
| 4 | Scrotum (surgery) |
| 4 | Radiotherapy Dosage |
| 4 | Postoperative Complications |
| 4 | Postoperative Complications (therapy) |
| 4 | Postoperative Complications (diagnosis) |
| 4 | Pilot Projects |
| 4 | Penile Neoplasms (surgery) |
| 4 | Patient Satisfaction |
| 4 | Patient Care Team |
| 4 | Patient Admission |
| 4 | Pain (etiology) |
| 4 | Neoplasms (complications) |
| 4 | Neoplasm Recurrence, Local (pathology) |
| 4 | Morbidity |
| 4 | Mice, Knockout |
| 4 | Mice, Inbred C57BL |
| 4 | Magnetic Resonance Angiography (methods) |
| 4 | Lymphangiosarcoma (pathology) |
| 4 | Lymph node |
| 4 | Lower Extremity (diagnostic imaging) |
| 4 | Longitudinal Studies |
| 4 | Lipectomy (methods) |
| 4 | Leg Ulcer (etiology) |
| 4 | Inguinal Canal (surgery) |
| 4 | Image Processing, Computer-Assisted |
| 4 | Hemangiosarcoma (surgery) |
| 4 | Heart Failure (diagnosis) |
| 4 | Heart Failure (complications) |
| 4 | Groin |
| 4 | Ghana |
| 4 | Genital Diseases, Male (pathology) |
| 4 | Forkhead Transcription Factors (genetics) |
| 4 | Filarioidea (drug effects) |
| 4 | Filariasis (drug therapy) |
| 4 | Fatal Outcome |
| 4 | Enzyme-Linked Immunosorbent Assay |
| 4 | Elephantiasis, Filarial (pathology) |
| 4 | Elephantiasis, Filarial (complications) |
| 4 | Elephantiasis, Filarial (blood) |
| 4 | Elephantiasis (etiology) |
| 4 | Elephantiasis (diagnosis) |
| 4 | Dose-Response Relationship, Drug |
| 4 | Diethylcarbamazine (therapeutic use) |
| 4 | Cisplatin (adverse effects) |
| 4 | Cells, Cultured |
| 4 | Brugia (drug effects) |
| 4 | Breast Neoplasms (psychology) |
| 4 | Blood vessel |
| 4 | Bibliographic review |
| 4 | Arm (surgery) |
| 4 | Antineoplastic Agents (adverse effects) |
| 4 | Anthelmintics (therapeutic use) |
| 4 | Angiosarcoma |
| 4 | Anatomic pathology |
| 4 | Albendazole (therapeutic use) |
| 3 | Wuchereria bancrofti (physiology) |
| 3 | Wuchereria bancrofti (pathogenicity) |
| 3 | Wound Healing |
| 3 | Venous Insufficiency (physiopathology) |
| 3 | Venous Insufficiency (diagnosis) |
| 3 | Venous Insufficiency (complications) |
| 3 | Treatment efficiency |
| 3 | Tomography, X-Ray Computed (methods) |
| 3 | Thiazoles (therapeutic use) |
| 3 | Thiazoles (pharmacology) |
| 3 | Symbiosis |
| 3 | Subcutaneous Tissue (surgery) |
| 3 | Stress, Mechanical |
| 3 | Stockings, Compression |
| 3 | Statistics, Nonparametric |
| 3 | Software |
| 3 | Skin Neoplasms (etiology) |
| 3 | Skin (blood supply) |
| 3 | Sentinel Lymph Node Biopsy (adverse effects) |
| 3 | Secondary |
| 3 | Scintigraphy |
| 3 | Sarcoma |
| 3 | Sarcoma, Kaposi (pathology) |
| 3 | Sarcoma, Kaposi (complications) |
| 3 | Review |
| 3 | Relapse |
| 3 | Reconstructive Surgical Procedures (methods) |
| 3 | Rats, Inbred Lew |
| 3 | Range of Motion, Articular |
| 3 | Quality of Life (psychology) |
| 3 | Prevention |
| 3 | Pregnancy |
| 3 | Postoperative Complications (diagnostic imaging) |
| 3 | Polymerase Chain Reaction |
| 3 | Pleural Effusion (diagnosis) |
| 3 | Penile Neoplasms (pathology) |
| 3 | Penile Diseases (surgery) |
| 3 | Pathophysiology |
| 3 | Organometallic Compounds |
| 3 | Onchocerciasis (prevention & control) |
| 3 | Onchocerciasis (immunology) |
| 3 | Onchocerciasis (epidemiology) |
| 3 | Neoplasms (radiotherapy) |
| 3 | Neoplasms (drug therapy) |
| 3 | Neoplasm Recurrence, Local (surgery) |
| 3 | Neoplasm Metastasis |
| 3 | Necrosis |
| 3 | Neck |
| 3 | Mutation (genetics) |
| 3 | Multivariate Analysis |
| 3 | Mouth Neoplasms (surgery) |
| 3 | Monitoring, Physiologic |
| 3 | Models |
| 3 | Microcephaly (genetics) |
| 3 | Methods |
| 3 | Metastasis |
| 3 | Melanoma (surgery) |
| 3 | Melanoma (secondary) |
| 3 | Mastectomy (adverse effects) |
| 3 | Lymphatic System (anatomy & histology) |
| 3 | Lymphatic Metastasis (pathology) |
| 3 | Lymphatic Diseases (diagnosis) |
| 3 | Lymphangiosarcoma (surgery) |
| 3 | Lymphangiosarcoma (etiology) |
| 3 | Lymphangioma (pathology) |
| 3 | Lymphangiogenesis (genetics) |
| 3 | Lymphangiectasis, Intestinal (pathology) |
| 3 | Lymphangiectasis, Intestinal (complications) |
| 3 | Lymphadenectomy |
| 3 | Lymph Nodes (surgery) |
| 3 | Lower Extremity |
| 3 | Long term |
| 3 | Lipoedema |
| 3 | Leg Ulcer (therapy) |
| 3 | Leg (blood supply) |
| 3 | Kidney Diseases (diagnosis) |
| 3 | Ivermectin (pharmacology) |
| 3 | Ivermectin (administration & dosage) |
| 3 | Injections, Subcutaneous |
| 3 | Injections, Intradermal |
| 3 | Indonesia |
| 3 | Indication |
| 3 | Immunohistochemistry |
| 3 | Heterocyclic Compounds |
| 3 | Hemangiosarcoma (diagnosis) |
| 3 | Head and Neck Neoplasms (radiotherapy) |
| 3 | Hand |
| 3 | Gynecology |
| 3 | Graft Survival |
| 3 | Genotype |
| 3 | Genetics |
| 3 | Gene Deletion |
| 3 | Forkhead Transcription Factors (metabolism) |
| 3 | Fluorouracil (administration & dosage) |
| 3 | Filariasis (parasitology) |
| 3 | Extremities |
| 3 | Extracellular Fluid (physiology) |
| 3 | Evidence-Based Medicine |
| 3 | Endothelial Cells (pathology) |
| 3 | Elephantiasis |
| 3 | Elephantiasis (pathology) |
| 3 | Edema |
| 3 | Edema, Cardiac (diagnosis) |
| 3 | Edema (pathology) |
| 3 | Edema (diagnostic imaging) |
| 3 | Echocardiography |
| 3 | Drug Therapy, Combination |
| 3 | Drug Combinations |
| 3 | Doxycycline (administration & dosage) |
| 3 | Double-Blind Method |
| 3 | Dose Fractionation |
| 3 | Disease |
| 3 | Disease-Free Survival |
| 3 | Consensus |
| 3 | Concomitant disease |
| 3 | Computerized axial tomography |
| 3 | Compression Bandages |
| 3 | Comorbidity |
| 3 | Clinical form |
| 3 | Chromosomes, Human, Pair 5 (genetics) |
| 3 | Chromosome Mapping |
| 3 | Cell Proliferation |
| 3 | Cell Differentiation |
| 3 | Case-Control Studies |
| 3 | Carcinoma |
| 3 | Carcinoma, Squamous Cell (pathology) |
| 3 | Carcinoma, Ductal, Breast (radiotherapy) |
| 3 | Brugia malayi |
| 3 | Brugia malayi (isolation & purification) |
| 3 | Brugia malayi (immunology) |
| 3 | Brugia (isolation & purification) |
| 3 | Brugia (genetics) |
| 3 | Breast (pathology) |
| 3 | Biomarkers (analysis) |
| 3 | Benzothiazoles |
| 3 | Arm (blood supply) |
| 3 | Antigens, Helminth (blood) |
| 3 | Anti-Inflammatory Agents, Non-Steroidal (therapeutic use) |
| 3 | Anti-Bacterial Agents (administration & dosage) |
| 3 | Animal |
| 3 | Analysis of Variance |
| 3 | Amputation |
| 3 | Administration, Oral |
| 3 | Acute Disease |
| 2 | lymphatic filariasis |
| 2 | diethylcarbamazine |
| 2 | cervical cancer |
| 2 | albendazole |
| 2 | Xanthomatosis (pathology) |
| 2 | Wuchereria bancrofti |
| 2 | Wuchereria bancrofti (microbiology) |
| 2 | Wuchereria bancrofti (growth & development) |
| 2 | Wolbachia (isolation & purification) |
| 2 | Wolbachia (growth & development) |
| 2 | Wolbachia (drug effects) |
| 2 | Venous Thrombosis (diagnostic imaging) |
| 2 | Venous Insufficiency (therapy) |
| 2 | Veins (surgery) |
| 2 | Vascular Endothelial Growth Factor Receptor-3 (genetics) |
| 2 | Vascular Endothelial Growth Factor Receptor-3 (blood) |
| 2 | Vascular Endothelial Growth Factor C (antagonists & inhibitors) |
| 2 | Vascular Endothelial Growth Factor C (administration & dosage) |
| 2 | Vascular Diseases (complications) |
| 2 | Uterine Cervical Neoplasms (surgery) |
| 2 | Uterine Cervical Neoplasms (radiotherapy) |
| 2 | Uterine Cervical Neoplasms (mortality) |
| 2 | Upper Extremity (diagnostic imaging) |
| 2 | Ultrasonography, Doppler, Color |
| 2 | Turner Syndrome (genetics) |
| 2 | Tumor Suppressor Proteins (metabolism) |
| 2 | Tumor Suppressor Proteins (genetics) |
| 2 | Tropical medicine |
| 2 | Travel |
| 2 | Trastuzumab |
| 2 | Transfection |
| 2 | Tomography, Emission-Computed, Single-Photon |
| 2 | Tomography, Emission-Computed, Single-Photon (methods) |
| 2 | Thrombophlebitis (therapy) |
| 2 | Thrombophlebitis (etiology) |
| 2 | Thrombophlebitis (diagnostic imaging) |
| 2 | Testicular Hydrocele (parasitology) |
| 2 | Testicular Hydrocele (diagnostic imaging) |
| 2 | Telangiectasis (etiology) |
| 2 | Technetium Tc 99m Aggregated Albumin |
| 2 | Tanzania (epidemiology) |
| 2 | Tail |
| 2 | Suture Techniques |
| 2 | Surveillance |
| 2 | Surgical Flaps (blood supply) |
| 2 | Subcutaneous Tissue (blood supply) |
| 2 | Soft tissue |
| 2 | Soft Tissue Neoplasms (drug therapy) |
| 2 | Soft Tissue Neoplasms (diagnosis) |
| 2 | Soft Tissue Injuries (surgery) |
| 2 | Skin Diseases (therapy) |
| 2 | Skin Diseases (diagnosis) |
| 2 | Sirolimus (therapeutic use) |
| 2 | Sirolimus (adverse effects) |
| 2 | Sheep |
| 2 | Sex Factors |
| 2 | Seroepidemiologic Studies |
| 2 | Sensitivity |
| 2 | Selenium |
| 2 | Selenium (therapeutic use) |
| 2 | Scrotum (pathology) |
| 2 | Scrotum (parasitology) |
| 2 | Schistosomiasis (drug therapy) |
| 2 | Sarcoma (complications) |
| 2 | SOXF Transcription Factors (genetics) |
| 2 | Rural Population |
| 2 | Reoperation |
| 2 | Regression Analysis |
| 2 | Regeneration (drug effects) |
| 2 | Reconstructive Surgical Procedures |
| 2 | Real-Time Polymerase Chain Reaction |
| 2 | Rats, Sprague-Dawley |
| 2 | Rat |
| 2 | Radiotherapy, Adjuvant (methods) |
| 2 | Radiopharmaceuticals |
| 2 | Radionuclide Imaging |
| 2 | Radiography |
| 2 | Radiodiagnosis |
| 2 | Radiation-Protective Agents (therapeutic use) |
| 2 | ROC Curve |
| 2 | Quality of life |
| 2 | Quality Indicators, Health Care |
| 2 | Public Health |
| 2 | Prostatic Neoplasms (surgery) |
| 2 | Prostatic Neoplasms (complications) |
